Dennis Özcelik
Did you ever wonder where all the drugs, which you can get at a pharmacy, come from? Who makes them, and how? Well, there is no easy answer, because the process of drug discovery and development is a very complex, expensive, and challenging journey, riddled with many risks and failures. This holds true for all types of drugs, from a simple pill to an mRNA vaccine or a gene therapy. Today, scientists support this process with a variety of AI applications, cutting-edge technologies, automation, and a huge amount of data. But can the race for new medicines and cures succeed only through more technology, or do we need to rethink the entire process? Let’s take a look at how the drug discovery and development process has worked so far, and how this entire process is changing – for better or worse.
Enna Gerhard, Frieder Nake
What power structures are inherent to the field of computer-generated art? In the year 1965, so 60 years ago, the first three exhibitions of art created with the help of computers took place - in part independently of each other. We want to present the interesting aspects of developments since then and discuss them with Frieder Nake, one of the people who exhibited in those very beginnings and followed those developments with a critical attitude.
MarKuster
Science advances by extending our senses beyond the limits of human perception, pushing the boundaries of what we can observe. In photon science, imaging detectors serve as the eyes of science, translating invisible processes into measurable and analysable data. Behind every image lies a deep understanding of how detectors see, respond and perform. At facilities like the European XFEL, the world's most powerful X-ray free-electron laser located in the Hamburg metropolitan area, imaging detectors capture ultrashort X-ray flashes at MHz frame rates and with high dynamic range. Without these advanced detectors, even the brightest X-ray laser beam would remain invisible. They help to reveal what would otherwise stay hidden, such as the structure of biomolecules, the behaviour of novel materials, and matter under extreme conditions. But how do we know they will perform as expected? And how do we design systems capable of “seeing” the invisible? I will take a closer look how imaging technology in large-scale facilities is simulated and designed to make the invisible visible. From predicting detector performance to evaluating image quality, we look at how performance simulation helps scientists and engineers understand the “eyes” of modern science.
Beata Hubrig, Nuri Khadem-Al-Charieh
Zur Überraschung Vieler sind Juristen Wissenschaftler, die nach wissenschaftlichen Maßstäben arbeiten sollten und ihre Schriftsätze und Urteile auch nach stringenten wissenschaftlichen Kriterien gestalten und untereinander diskutieren sollten. Doch nur in einigen Rechtsgebieten funktioniert dies. Wie jede Wissenschaft ist auch die Rechtswissenschaft nur so gut wie das ihr zugrundeliegende Quellenmaterial – in diesem Fall sind das meist Urteile. Empirische Untersuchungen über diese Daten sind nur möglich, wenn sie der Forschung auch zur Verfügung stehen. Doch wissenschaftliche Arbeit im juristischen Feld ist aktuell nicht wirklich möglich, da die wenigsten Urteile veröffentlicht werden, da sich die Gerichte meist vor der dadurch anfallenden Arbeit scheuen. Wir betrachten, warum dies Grundsätze der Rechtsstaatlichkeit infrage stellt und warum Player aus der Wirtschaft mehr über deutsche Rechtsprechung wissen, als unsere Gerichte – und wie sie das zu Geld machen.
Helena Nikonole
This presentation examines artistic practices that engage with sociotechnical systems through tactical interventions. The talk proposes art as a form of infrastructural critique and counter-technology. It also introduces a forthcoming HackLab designed to foster collaborative development of open-source tools addressing digital authoritarianism, surveillance capitalism, propaganda infrastructures, and ideological warfare.